Exploration of Patient Self-medication Practices During and After Cancer in France
- Conditions
- Self-medicationCancer
- Registration Number
- NCT05156931
- Lead Sponsor
- University Hospital, Clermont-Ferrand
- Brief Summary
The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire
- Detailed Description
Patients will be contacted by email from patient's associations. Patients will be informed of the objectives of the study and will be free to answer or not to the online questionnaire.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 681
- Past or active cancer
- Speaking French
- Not living in France
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Self-medication day 1 declaration of a practice of self-medication
- Secondary Outcome Measures
Name Time Method Class of products used in self-medication day 1 non-prescription medicine, herbal medicine, aromatherapy, homeopathy, and food supplements
Origin of self-medication products day 1 pharmacy, market, internet, other
Perception of adverse effects and drug-drug interaction related to self medication day 1 yes / no
QLQ-C30 questionnaire day 1 Global health status Functional scales Physical functioning Role functioning Emotional functioning Cognitive functioning Social functioning Fatigue Nausea and vomiting Pain Dyspnoea Insomnia Appetite loss Constipation Diarrhoea Financial difficulties
Indication for self-medication day 1 For treatment of side-effects, improvements in anti-cancer effects
Trial Locations
- Locations (1)
CHU Clermont-Ferrand
🇫🇷Clermont-Ferrand, France